Intergroupe Francophone du Myelome
Quick facts
Phase 3 pipeline
- Velcade-Dexamethasone · Oncology
Velcade-Dexamethasone is a combination of a proteasome inhibitor and a corticosteroid used to treat multiple myeloma.
Phase 2 pipeline
- Bendamustine, Velcade and Dexamethasone · Oncology
Bendamustine is a nitrogen mustard alkylating agent that cross-links DNA, Velcade is a proteasome inhibitor that blocks the 26S proteasome, Dexamethasone is a corticosteroid that inhibits phospholipase A2.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: